This topic contains a solution. Click here to go to the answer

Author Question: A patient with Crohn's disease is experiencing diarrhea during an exacerbation of symptoms. What ... (Read 30 times)

rayancarla1

  • Hero Member
  • *****
  • Posts: 571
A patient with Crohn's disease is experiencing diarrhea during an exacerbation of symptoms. What medication will the nurse most likely administer?
 
  A) Bismuth salts (Pepto-Bismol)
  B) Ciprofloxacin (Cipro)
  C) Cholestyramine (Questran)
  D) Octreotide acetate (Sandostatin)

Question 2

A patient is admitted to the intensive care unit with status asthmaticus. The patient is administered high doses of nebulized albuterol (Proventil). What electrolyte imbalance should the nurse assess for this patient?
 
  A) Hyperkalemia
  B) Hypermagnesemia
  C) Hypocalcemia
  D) Hypokalemia



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

parker125

  • Sr. Member
  • ****
  • Posts: 332
Answer to Question 1

C
Feedback:
Bile-binding drugs, such as cholestyramine (Questran) or colestipol, are useful in treating diarrheas due to bile salt accumulation in conditions such as Crohn's disease. Bismuth salts, ciprofloxacin, and octreotide are not typically administered to the patient with Crohn's disease.

Answer to Question 2

D
Feedback:
High doses of nebulized albuterol have been associated with tachycardia, hypokalemia, and hyperglycemia. The patient will not have alterations of magnesium or calcium levels.




rayancarla1

  • Member
  • Posts: 571
Reply 2 on: Jul 23, 2018
YES! Correct, THANKS for helping me on my review


raenoj

  • Member
  • Posts: 340
Reply 3 on: Yesterday
Wow, this really help

 

Did you know?

Parkinson's disease is both chronic and progressive. This means that it persists over a long period of time and that its symptoms grow worse over time.

Did you know?

There are 60,000 miles of blood vessels in every adult human.

Did you know?

Malaria mortality rates are falling. Increased malaria prevention and control measures have greatly improved these rates. Since 2000, malaria mortality rates have fallen globally by 60% among all age groups, and by 65% among children under age 5.

Did you know?

Fatal fungal infections may be able to resist newer antifungal drugs. Globally, fungal infections are often fatal due to the lack of access to multiple antifungals, which may be required to be utilized in combination. Single antifungals may not be enough to stop a fungal infection from causing the death of a patient.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library